BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Artificial Intelligence

GE HealthCare Completes Acquisition of MIM Software, Enhancing Precision Care Portfolio

With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated sol...

April 02, 2024 | News

GE HealthCare Launches AI-Driven Prostate Volume Assist to Transform Urological Imaging

New AI software feature will be available for use on the bkActiv, bk3000/5000 and bkSpecto active imaging systems Addition of AI solution advances...

March 28, 2024 | News

Hoth Therapeutics' Merveille.ai Achieves Breakthrough in Obesity Treatment with AI-Driven Therapeutic Candidate

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, is excited to announce a significant breakthrough by its sub...

March 28, 2024 | News

Clarivate Acquires Silicon Valley's MotionHall to Boost AI-Driven Life Sciences & Healthcare Solutions

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, has announced an agreement to acquire the substantial ma...

March 22, 2024 | News

Cognizant and NVIDIA Accelerate Drug Discovery with Generative AI

Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex chal...

March 20, 2024 | News

BioGeometry and Sanyou Bio Announce Pioneering Alliance to Accelerate AI-Powered Antibody Research

BioGeometry, a frontrunner in digital biology and AI-driven protein design, alongside Sanyou Bio, a leading force in the high-tech biotechnology sector, ha...

March 19, 2024 | News

South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection

Lunit, a trailblazer in AI-driven diagnostics and cancer treatment, announced significant strides in its European market presence through new...

March 19, 2024 | News

EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices

Under the agreement signed on March 13, 2024, in Bellevue, Washington, EDAN and GH Labs will combine their expertise to create innovative ul...

March 18, 2024 | News

Lunit's Bid to Acquire Volpara Gains Momentum with New Zealand High Court's Initial Nod

Volpara Health Technologies (Volpara; ASX:VHT), renowned for its AI-driven solutions in cancer diagnostics, is on the brink of a transformative merger with...

March 14, 2024 | News

Novel Molecules From Generative AI to Phase II: Pioneering TNIK Inhibitors for Fibrotic Diseases

In a groundbreaking study published in Nature Biotechnology, Insilico Medicine, along with its collaborators, showcases the journey of INS018_055 f...

March 13, 2024 | News

CAIR Launches Revolutionary CARES Copilot 1.0, Elevating AI in Healthcare

The Centre for Artificial Intelligence and Robotics (CAIR), under the Hong Kong Institute of Science & Innovation, Chinese Acad...

March 12, 2024 | News

QIAGEN Advances Drug Discovery with AI-Driven Biomedical Knowledge Base Featuring 640 Million Relationships

QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-dr...

March 04, 2024 | News

VinBrain and Global Fund Partner to Fight Tuberculosis in Vietnam with AI in 2024

VinBrain is the sole entity chosen for this agreement with Global Fund in 2024. DrAid™ for TB Screening, a solution developed from VinBrain's in...

February 29, 2024 | News

Ono Pharmaceutical Partners with InveniAI to Revolutionize Drug Discovery Using AI

Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") has announced a strategic partnership with the AI-driven company InveniAI...

February 22, 2024 | News

Stay Connected